Acquired MTAP Loss Following Entrectinib Resistance in ROS1 ‐Rearranged NSCLC With CD74 Exon 3– ROS1 Exon 34 Fusion
Thoracic Cancer · 2025
DOI: 10.1111/1759-7714.70176 ↗Kurz gefasst
Fallbericht in der Zeitschrift Thoracic Cancer, 2025. Verfasst von Mizuha Haraguchi Hashiguchi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary Medicine, Department of Medicine, Keiyu Hospital, Yokohama, Japan. Hauptthemen laut MEDLINE: Antigens, Differentiation, B-Lymphocyte, Benzamides, Carcinoma, Non-Small-Cell Lung, Drug Resistance, Neoplasm. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary Medicine, Department of Medicine, Keiyu Hospital, Yokohama, Japan.
- Department of Neurosurgery, Kawasaki Municipal Hospital, Kawasaki, Japan.
- Division of Pulmonary Medicine, Department of Medicine, Keio University, School of Medicine, Tokyo, Japan.
- Keio Cancer Center, Keio University School of Medicine, Tokyo, Japan.
- Center for Cancer Genomics, Keio University School of Medicine, Tokyo, Japan.
ORCID-Profile: Mizuha Haraguchi Hashiguchi
Zitieren
APA
Haraguchi Hashiguchi, M., Tanino, M., Yoneda, S., Asaoka, M., Kagyo, J., Katayama, M., Terai, H., Nakamura, K., Nishihara, H., & Fukunaga, K. (2025). Acquired MTAP Loss Following Entrectinib Resistance in ROS1 ‐Rearranged NSCLC With CD74 Exon 3– ROS1 Exon 34 Fusion. Thoracic Cancer. https://doi.org/10.1111/1759-7714.70176
Vancouver
Haraguchi Hashiguchi M, Tanino M, Yoneda S, Asaoka M, Kagyo J, Katayama M, et al. Acquired MTAP Loss Following Entrectinib Resistance in ROS1 ‐Rearranged NSCLC With CD74 Exon 3– ROS1 Exon 34 Fusion. Thoracic Cancer. 2025. doi:10.1111/1759-7714.70176
BibTeX
@article{HaraguchiHashiguchi2025,
author = {Haraguchi Hashiguchi, Mizuha and Tanino, Maika and Yoneda, Suzuyuki and Asaoka, Masato and Kagyo, Junko and Katayama, Makoto and Terai, Hideki and Nakamura, Kohei and Nishihara, Hiroshi and Fukunaga, Koichi},
title = {Acquired MTAP Loss Following Entrectinib Resistance in ROS1 ‐Rearranged NSCLC With CD74 Exon 3– ROS1 Exon 34 Fusion},
journal = {Thoracic Cancer},
year = {2025},
doi = {10.1111/1759-7714.70176}
}
EUVIMED